[Amputations, walking and prosthesis development].

Felipe Pascual Gómez

Home/Archive/PubMed

PubMed · 15027708

[Amputations, walking and prosthesis development].

Felipe Pascual Gómez

View original source ↗Export metadata ↓

Abstract

Deficiency or loss of limbs is bound to human history. From the beginning of the human race, prosthetics solutions have been researched for amputations. With the mutilation of the lower limb, walking, one of the most important functions in the human being is lost. The main object of surgical amputation is not only to save the life, but also to create a new organ, the stump, in order to adapt a prosthetic limb, so that the patient is able to walk again. Most prostheses in the past have been lost like useless objects. Some models that have been saved for the clinical practice, allow us to present the biggest advances in prosthetic technique evolution in last time.

Explore related subjects

Amputation, Surgical Artificial Limbs History, 16th Century History, 17th Century History, 18th Century History, 19th Century History, 20th Century History, Ancient Humans Leg Prosthesis Design Walking English Abstract Historical Article Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Felipe Pascual Gómez. 2003. [Amputations, walking and prosthesis development].. https://pubmed.ncbi.nlm.nih.gov/15027708/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2005

Bayesian tests of extra-Binomial variability.

A simple model for extra-Binomial variability is the Beta-Binomial. A complication in testing the Binomial against the Beta-Binomial alternative is that the Binomial lies on the boundary of the Beta-Binomial, which forces modifications to the usual asymptotic arguments. In this paper, we propose a Bayesian test using a pair of approximate Bayes factors, one for the case in which the maximum likelihood estimator (MLE) of the extra-Binomial variability is zero and one for the case in which it is positive. These approximate Bayes factors are easy to compute. We evaluate the operating characteristics of the Bayes factors and find them to be more powerful than the likelihood ratio test. We then apply the method to three data sets, including one in which the issue is whether a logistic regression intercept should be considered a random effect. In each case, our approximate Bayes factors are close to the exact Bayes factors, which may also be computed with additional effort.

Amputation, Surgical↗

PubMed2004

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).

AIMS/HYPOTHESIS: The aim of this study was to develop a simulation model for type 2 diabetes that can be used to estimate the likely occurrence of major diabetes-related complications over a lifetime, in order to calculate health economic outcomes such as quality-adjusted life expectancy. METHODS: Equations for forecasting the occurrence of seven diabetes-related complications and death were estimated using data on 3642 patients from the United Kingdom Prospective Diabetes Study (UKPDS). After examining the internal validity, the UKPDS Outcomes Model was used to simulate the mean difference in expected quality-adjusted life years between the UKPDS regimens of intensive and conventional blood glucose control. RESULTS: The model's forecasts fell within the 95% confidence interval for the occurrence of observed events during the UKPDS follow-up period. When the model was used to simulate event history over patients' lifetimes, those treated with a regimen of conventional glucose control could expect 16.35 undiscounted quality-adjusted life years, and those receiving treatment with intensive glucose control could expect 16.62 quality-adjusted life years, a difference of 0.27 (95% CI: -0.48 to 1.03). CONCLUSIONS/INTERPRETATIONS: The UKPDS Outcomes Model is able to simulate event histories that closely match observed outcomes in the UKPDS and that can be extrapolated over patients' lifetimes. Its validity in estimating outcomes in other groups of patients, however, remains to be evaluated. The model allows simulation of a range of long-term outcomes, which should assist in informing future economic evaluations of interventions in type 2 diabetes.

Amputation, Surgical↗

PubMed2004

Biphasic modulation of behavioral nociceptive responses by morphine in adult mice after amputation.

Amputation of a segment of the tail produced long-lasting changes in nociception and morphine-induced antinociception. Plastic changes in nociceptive transmission may occur at the spinal cord as well as supraspinal structures after tail amputation. Acute hyperalgesia is detected at the remaining part of the tail as well as hindpaw. Morphine induced facilitation of the hot-plate (HP) response at a low dose and a greater dose of morphine is required to produce complete inhibition of the HP response. Since these effects happen at five weeks after the surgery, tail amputation may serve as a mouse model for studying long-term plastic changes in central nervous system after amputation.

Amputation, Surgical↗